相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: from exosomes to microvesicles
Sean M. Davidson et al.
CARDIOVASCULAR RESEARCH (2023)
Associations Among PCSK9 Levels, Atherosclerosis-Derived Extracellular Vesicles, and Their miRNA Content in Adults With Obesity
Chiara Macchi et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)
Platelet-released extracellular vesicles: the effects of thrombin activation
Rosa Suades et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2022)
A standarized protocol for evaluation of large extracellular vesicles using the attuneTM NXT system
Leslie Marisol Lugo-Gavidia et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2021)
Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data
Gemma A. Figtree et al.
LANCET (2021)
Arterial Stiffness and Cardiovascular Risk in Hypertension
Pierre Boutouyrie et al.
CIRCULATION RESEARCH (2021)
Coronary artery disease patients without standardmodifiable risk factors (SMuRFs)- a forgotten group calling out for new discoveries
Gemma A. Figtree et al.
CARDIOVASCULAR RESEARCH (2021)
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)
Frank L. J. Visseren et al.
EUROPEAN HEART JOURNAL (2021)
Redefining cardiovascular risk prediction: is the crystal ball clearer now?
Lale Tokgozoglu et al.
EUROPEAN HEART JOURNAL (2021)
Role of Microparticles in Cardiovascular Disease Implications for Endothelial Dysfunction, Thrombosis, and Inflammation
Leslie Marisol Lugo-Gavidia et al.
HYPERTENSION (2021)
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
Risk Factors and Outcomes of Very Young Adults Who Experience Myocardial Infarction: The Partners YOUNG-MI Registry
Junjie Yang et al.
AMERICAN JOURNAL OF MEDICINE (2020)
Association of Microvesicles With Graft Patency in Patients Undergoing CABG Surgery
Marina Camera et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019 Update From the GBD 2019 Study
Gregory A. Roth et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Biology and Role of Extracellular Vesicles (EVs) in the Pathogenesis of Thrombosis
Marta Zara et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
ST-Segment-Elevation Myocardial Infarction (STEMI) Patients Without Standard Modifiable Cardiovascular Risk Factors-How Common Are They, and What Are Their Outcomes?
Stephen T. Vernon et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary
Scott M. Grundy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Cardiovascular Risk and Statin Eligibility of Young Adults After an MI Partners YOUNG-MI Registry
Avinainder Singh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams et al.
EUROPEAN HEART JOURNAL (2018)
Brachial-Ankle Pulse Wave Velocity and the Risk Prediction of Cardiovascular Disease An Individual Participant Data Meta-Analysis
Toshiaki Ohkuma et al.
HYPERTENSION (2017)
Increasing proportion of ST elevation myocardial infarction patients with coronary atherosclerosis poorly explained by standard modifiable risk factors
Stephen T. Vernon et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2017)
High glucose increases the formation and pro-oxidative activity of endothelial microparticles
Dylan Burger et al.
DIABETOLOGIA (2017)
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Massimo F. Piepoli et al.
EUROPEAN HEART JOURNAL (2016)
Role of Platelet-Derived Microvesicles As Crosstalk Mediators in Atherothrombosis and Future Pharmacology Targets: A Link between Inflammation, Atherosclerosis, and Thrombosis
Lina Badimon et al.
FRONTIERS IN PHARMACOLOGY (2016)
Microparticles as Potential Biomarkers of Cardiovascular Disease
Carolina Nunes Franca et al.
ARQUIVOS BRASILEIROS DE CARDIOLOGIA (2015)
Aortic pulse wave velocity and HeartSCORE: Improving cardiovascular risk stratification. A sub-analysis of the EDIVA (Estudo de DIstensibilidade VAscular) project
T. Pereira et al.
BLOOD PRESSURE (2014)
Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study
Nicolas Amabile et al.
EUROPEAN HEART JOURNAL (2014)
Aortic Pulse Wave Velocity Improves Cardiovascular Event Prediction An Individual Participant Meta-Analysis of Prospective Observational Data From 17,635 Subjects
Yoav Ben-Shlomo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Microparticles: biomarkers and beyond
Dylan Burger et al.
CLINICAL SCIENCE (2013)
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness A Systematic Review and Meta-Analysis
Charalambos Vlachopoulos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Relationship between blood pressure parameters and pulse wave velocity in normotensive and hypertensive subjects: invasive study
E. J. Kim et al.
JOURNAL OF HUMAN HYPERTENSION (2007)
Pulse wave analysis
MF O'Rourke et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
分享论文
